Jansson, N, Pettersson, J, Haafiz, A, et al. Down-regulation of placental transport of amino acids precedes the development of intrauterine growth restriction in rats fed a low protein diet. J Physiol. 2006; 576(Pt 3), 935–946.
Jansson, T, Powell, TL. IFPA 2005 Award in Placentology Lecture. Human placental transport in altered fetal growth: does the placenta function as a nutrient sensor? – a review. Placenta. 2006; 27(Suppl. A), S91–S97.
Roos, S, Lagerlof, O, Wennergren, M, Powell, TL, Jansson, T. Regulation of amino acid transporters by glucose and growth factors in cultured primary human trophoblast cells is mediated by mTOR signaling. Am J Physiol Cell Physiol. 2009; 297, C723–C731.
Roos, S, Powell, TL, Jansson, T. Placental mTOR links maternal nutrient availability to fetal growth. Biochem Soc Trans. 2009; 37(Pt 1), 295–298.
Brodsky, D, Christou, H. Current concepts in intrauterine growth restriction. J Intensive Care Med. 2004; 19, 307–319.
Barker, DJ. The Wellcome Foundation Lecture, 1994. The fetal origins of adult disease. Proc Biol Sci. 1995; 262, 37–43.
Curhan, GC, Willett, WC, Rimm, EB, et al. Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation. 1996; 94, 3246–3250.
Ong, KK, Ahmed, ML, Emmett, PM, Preece, MA, Dunger, DB. Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. BMJ. 2000; 320, 967–971.
Metcalfe, NB, Monaghan, P. Compensation for a bad start: grow now, pay later?
Trends Ecol Evol. 2001; 16, 254–260.
Boekelheide, K, Blumberg, B, Chapin, RE, et al. Predicting later-life outcomes of early-life exposures. Environ Health Perspect. 2012; 120, 1353–1361.
Dulloo, AG. Regulation of fat storage via suppressed thermogenesis: a thrifty phenotype that predisposes individuals with catch-up growth to insulin resistance and obesity. Hormone Res. 2006; 65(Suppl. 3), 90–97.
Dulloo, AG, Jacquet, J, Seydoux, J, Montani, JP. The thrifty ‘catch-up fat’ phenotype: its impact on insulin sensitivity during growth trajectories to obesity and metabolic syndrome. Int J Obes. 2006; 30(Suppl. 4), S23–S35.
Roos, S, Kanai, Y, Prasad, PD, Powell, TL, Jansson, T. Regulation of placental amino acid transporter activity by mammalian target of rapamycin. Am J Physiol Cell Physiol. 2009; 296, C142–C150.
Busch, S, Renaud, SJ, Schleussner, E, Graham, CH, Markert, UR. mTOR mediates human trophoblast invasion through regulation of matrix-remodeling enzymes and is associated with serine phosphorylation of STAT3. Exp Cell Res. 2009; 315, 1724–1733.
Harrington, LS, Findlay, GM, Lamb, RF. Restraining PI3K: mTOR signalling goes back to the membrane. Trends Biochem Sci. 2005; 30, 35–42.
Um, SH, Frigerio, F, Watanabe, M, et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature. 2004; 431, 200–205.
Bouzakri, K, Roques, M, Gual, P, et al. Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. Diabetes. 2003; 52, 1319–1325.
LeRoith, D, Werner, H, Beitner-Johnson, D, Roberts, CT Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev. 1995; 16, 143–163.
De Blasio, MJ, Gatford, KL, McMillen, IC, Robinson, JS, Owens, JA. Placental restriction of fetal growth increases insulin action, growth, and adiposity in the young lamb. Endocrinology. 2007; 148, 1350–1358.
De Blasio, MJ, Gatford, KL, Harland, ML, Robinson, JS, Owens, JA. Placental restriction reduces insulin sensitivity and expression of insulin signaling and glucose transporter genes in skeletal muscle, but not liver, in young sheep. Endocrinology. 2012; 153, 2142–2151.
Hay, N, Sonenberg, N. Upstream and downstream of mTOR. Genes Dev. 2004; 18, 1926–1945.
Skeen, JE, Bhaskar, PT, Chen, CC, et al. Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner. Cancer Cell. 2006; 10, 269–280.
Yang, ZZ, Tschopp, O, Hemmings-Mieszczak, M, et al. Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J Biol Chem. 2003; 278, 32124–32131.
Ma, Y, Zhu, MJ, Uthlaut, AB, et al. Upregulation of growth signaling and nutrient transporters in cotyledons of early to mid-gestational nutrient restricted ewes. Placenta. 2011; 32, 255–263.
Hardie, DG. The AMP-activated protein kinase pathway – new players upstream and downstream. J Cell Sci. 2004; 117(Pt 23), 5479–5487.
Kovacic, S, Soltys, CL, Barr, AJ, et al. Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J Biol Chem. 2003; 278, 39422–39427.
Minokoshi, Y, Alquier, T, Furukawa, N, et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature. 2004; 428, 569–574.
Gudmundsson, S, Korszun, P, Olofsson, P, Dubiel, M. New score indicating placental vascular resistance. Acta obstetricia et gynecologica Scandinavica. 2003; 82, 807–812.
Fahlbusch, FB, Dawood, Y, Hartner, A, et al. Cullin 7 and Fbxw 8 expression in trophoblastic cells is regulated via oxygen tension: implications for intrauterine growth restriction?
J Matern Fetal Neonatal Med. 2012; 25, 2209–2215.
Ghidini, A. Idiopathic fetal growth restriction: a pathophysiologic approach. Obstet Gynecol Survey. 1996; 51, 376–382.
Voigt, M, Schneider, KT, Jahrig, K. Analysis of a 1992 birth sample in Germany. 1: New percentile values of the body weight of newborn infants. Geburtshilfe Und Frauenheilkunde.
1996; 56, 550–558.
Kromeyer-Hauschild, K, Wabitsch, M, Kunze, D, et al. Percentiles for the body mass index for the child and young adult under consulting different German samples. Monatsschr Kinderheilkd. 2001; 149, 807–818.
Hartner, A, Porst, M, Gauer, S, et al. Glomerular osteopontin expression and macrophage infiltration in glomerulosclerosis of DOCA-salt rats. Am J Kidney Dis. 2001; 38, 153–164.
Sarbassov, DD, Guertin, DA, Ali, SM, Sabatini, DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005; 307, 1098–1101.
Steinberg, TH. Protein gel staining methods: an introduction and overview. Methods Enzymol. 2009; 463, 541–563.
Karlberg, J, Albertsson-Wikland, K. Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr Res. 1995; 38, 733–739.
Karlberg, JP, Albertsson-Wikland, K, Kwan, EY, Lam, BC, Low, LC. The timing of early postnatal catch-up growth in normal, full-term infants born short for gestational age. Hormone Res. 1997; 48(Suppl. 1), 17–24.
Chatelain, P. Children born with intra-uterine growth retardation (IUGR) or small for gestational age (SGA): long term growth and metabolic consequences. Endocr Regul. 2000; 34, 33–36.
Victora, CG, Barros, FC, Horta, BL, Martorell, R. Short-term benefits of catch-up growth for small-for-gestational-age infants. Int J Epidemiol. 2001; 30, 1325–1330.
Frisk, V, Amsel, R, Whyte, HE. The importance of head growth patterns in predicting the cognitive abilities and literacy skills of small-for-gestational-age children. Dev Neuropsychol. 2002; 22, 565–593.
Rogers, I, Group, E-BS. The influence of birthweight and intrauterine environment on adiposity and fat distribution in later life. Int J Obes Relat Metab Disord. 2003; 27, 755–777.
Eriksson, JG, Forsen, T, Tuomilehto, J, et al.
Catch-up growth in childhood and death from coronary heart disease: longitudinal study. BMJ. 1999; 318, 427–431.
Forsen, T, Eriksson, J, Qiao, Q, et al. Short stature and coronary heart disease: a 35-year follow-up of the finnish cohorts of the seven countries study. J Intern Med. 2000; 248, 326–332.
Street, ME, Viani, I, Ziveri, MA, et al. Impairment of insulin receptor signal transduction in placentas of intra-uterine growth-restricted newborns and its relationship with fetal growth. Eur J Endocrinol. 2011; 164, 45–52.
Morgensztern, D, McLeod, HL. PI3K/Akt/mTOR pathway as a target for cancer therapy. AntiCancer Drugs. 2005; 16, 797–803.
Roos, S, Jansson, N, Palmberg, I, et al. Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth. J Physiol. 2007; 582(Pt 1), 449–459.
Soliman, GA. The mammalian target of rapamycin signaling network and gene regulation. Curr Opin Lipidol. 2005; 16, 317–323.
Laviola, L, Perrini, S, Belsanti, G, et al. Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. Endocrinology. 2005; 146, 1498–1505.
Rosario, FJ, Jansson, N, Kanai, Y, et al. Maternal protein restriction in the rat inhibits placental insulin, mTOR, and STAT3 signaling and down-regulates placental amino acid transporters. Endocrinology. 2011; 152, 1119–1129.
Laplante, M, Sabatini, DM. mTOR signaling in growth control and disease. Cell. 2012; 149, 274–293.
Kavitha, JV, Rosario, FJ, Nijland, MJ, et al. Down-regulation of placental mTOR, insulin/IGF-I signaling, and nutrient transporters in response to maternal nutrient restriction in the baboon. FASEB J. 2014; 28, 1294–1305.
Lager, S, Aye, IL, Gaccioli, F, et al. Labor inhibits placental mechanistic target of rapamycin complex 1 signaling. Placenta. 2014; 35, 1007–1012.
Hardwick, JS, Kuruvilla, FG, Tong, JK, Shamji, AF, Schreiber, SL. Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins. Proc Natl Acad Sci U S A. 1999; 96, 14866–14870.